Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions

Allaire, 1998, Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1, Circulation, 98, 249, 10.1161/01.CIR.98.3.249 Allaire, 1998, Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model, J Clin Invest, 102, 1413, 10.1172/JCI2909 Allaire, 2002, Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation, J Vasc Surg, 36, 1018, 10.1067/mva.2002.127347 Badier-Commander, 2000, Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation, J Pathol, 192, 105, 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1 Badier-Commander, 2001, Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study, J Pathol, 193, 398, 10.1002/path.819 Bieth, 1998, Leukocyte elastase, 54 Brew, 2000, Tissue inhibitors of metalloproteinases: evolution, structure and function, Biochim Biophys Acta, 1477, 267, 10.1016/S0167-4838(99)00279-4 Chothia, 1997, The molecular structure of cell adhesion molecules, Ann Rev Biochem, 66, 823, 10.1146/annurev.biochem.66.1.823 Collod, 1996, Fibrillines et fibrillinopathies, Méd/Sci, 12, 1077 Curci, 1998, Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms, J Clin Invest, 102, 1900, 10.1172/JCI2182 Debelle, 1999, Elastin: molecular description and function, Int J Biochem Cell Biol, 31, 261, 10.1016/S1357-2725(98)00098-3 Devy, 1999, Rôle des métalloprotéinases matricielles et des protéases à sérine dans la migration et l’infiltration des cellules hématopoïétiques, Hématologie, 5, 265 Dietz, 2000, Mouse models of genetic diseases resulting from mutations in elastic fiber proteins, Matrix Biol, 19, 481, 10.1016/S0945-053X(00)00101-3 Dollery, 1995, Matrix metalloproteinases and cardiovascular disease, Circ Res, 77, 863, 10.1161/01.RES.77.5.863 Feldman, 2001, Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit, Circulation, 103, 3117, 10.1161/01.CIR.103.25.3117 Fontaine, 2002, Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms, Am J Pathol, 161, 1701, 10.1016/S0002-9440(10)64447-1 Fukuda, 2000, Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase, Circulation, 101, 2532, 10.1161/01.CIR.101.21.2532 Galis, 2002, Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly, Circ Res, 90, 251, 10.1161/res.90.3.251 Gonzalez, 2000, Molecular plasticity of vascular wall during Nω-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals, Hypertension, 36, 103, 10.1161/01.HYP.36.1.103 Gibson, 1996, Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25), J Biol Chem, 271, 1096, 10.1074/jbc.271.2.1096 Handford, 2000, Fibrillin: from domain structure to supramolecular assembly, Matrix Biol, 19, 457, 10.1016/S0945-053X(00)00100-1 Herron, 1995, Proteinases and inhibitors in aortic aneurysms, 195 Hornstra, 2003, Lysyl oxidase is required for vascular and diaphragmatic development in mice, J Biol Chem, 278, 14387, 10.1074/jbc.M210144200 Iozzo, 1998, Matrix proteoglycans: from molecular design to cellular function, Ann Rev Biochem, 67, 609, 10.1146/annurev.biochem.67.1.609 Jacob, 1993, Elastine: préparation, caractérisation, structure, biosynthèse et catabolisme, C R Soc Biol, 187, 166 Jacob, 2002, Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins, Circulation, 106, 535, 10.1161/01.CIR.0000027521.83518.4C Keeley, 1991, Response of aortic elastin synthesis and accumulation to developing hypertension and the inhibitory effect of colchicine on this response, Lab Invest, 64, 499 Keeley, 1991, Effects of antihypertensive drug classes on regression of connective tissue components of hypertension, J Cardiovasc Pharmacol, 17, S64, 10.1097/00005344-199117002-00014 Keeley, 1992, Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats, Am J Physiol, 262, H1013 Kielty, 2002, Elastic fibres, J Cell Sci, 115, 2817, 10.1242/jcs.115.14.2817 Knox, 1997, Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases, Circulation, 95, 205, 10.1161/01.CIR.95.1.205 Labat-Robert, 1998, Cell-matrix interactions, alterations with aging, involvement in angiogenesis, Pathol Biol, 46, 527 Lakatta, 2003, Arterial and cardiac aging. Major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a “set up” for vascular disease, Circulation, 107, 139, 10.1161/01.CIR.0000048892.83521.58 Lakatta, 2003, Arterial and cardiac aging. Major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging, Circulation, 107, 490, 10.1161/01.CIR.0000048894.99865.02 Laviades, 1998, Abnormalities of the extracellular degradation of collagen type I in essential hypertension, Circulation, 98, 535, 10.1161/01.CIR.98.6.535 Li, 1998, Novel arterial pathology in mice and humans hemizygous for elastin, J Clin Invest, 102, 1783, 10.1172/JCI4487 Li, 1998, Elastin is an essential determinant of arterial morphogenesis, Nature, 393, 276, 10.1038/30522 Li, 1999, Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats, Hypertension, 33, 116, 10.1161/01.HYP.33.1.116 Lopez-Candales, 1997, Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms, Am J Pathol, 150, 993 Lortat-Jacob, 2002, Structural diversity of heparan sulfate binding domains in chemokines, Proc Natl Acad Sci USA, 99, 1229, 10.1073/pnas.032497699 Maki, 2002, Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice, Circulation, 106, 2503, 10.1161/01.CIR.0000038109.84500.1E Mayne, 1986, Collagenous proteins of blood vessels, Arteriosclerosis, 6, 585, 10.1161/01.ATV.6.6.585 Michel, 1994, Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries, Am J Physiol, 267, R124 Michel, 1998, Acquired abdominal aortic aneurysm, Nephrol Dial Transpl, 13, 20, 10.1093/ndt/13.suppl_4.20 Michel, 2001, Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction, Arterioscler Thromb Vasc Biol, 21, 1389, 10.1161/atvb.21.9.1389 Michiels, 2000, Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions, Biochim Biophys Acta, 1497, 1, 10.1016/S0167-4889(00)00041-0 Milewicz, 2000, Genetic disorders of the elastic fiber system, Matrix Biol, 19, 471, 10.1016/S0945-053X(00)00099-8 Nakamura, 2002, Fibulin-5/DANCE is essential for elastogenesis in vivo, Nature, 415, 171, 10.1038/415171a Praillet, 1998, Les protéoglycannes. I. Molécules aux multiples fonctions ... futures molécules thérapeutiques?, Méd/Sci, 14, 412 Prockop, 1995, Collagens: molecular biology, diseases, and potentials for therapy, Ann Rev Biochem, 64, 403, 10.1146/annurev.bi.64.070195.002155 Rabinovitch, 1999, EVE and beyond, retro and prospective insights, Am J Physiol, 277, L5 Reiser, 1992, Enzymatic and non-enzymatic cross-linking of collagen and elastin, FASEB J, 6, 2439, 10.1096/fasebj.6.7.1348714 Robert, 1988, Les protéases de type élastase, Pathol Biol, 36, 1101 Robins, 1995, Connective tissue components of the blood vessel wall in health and disease, 89 Rosenbloom, 1993, Extracellular matrix. 4: The elastic fiber, FASEB J, 7, 1208, 10.1096/fasebj.7.13.8405806 Sangiorgi, 2001, Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment, Circulation, 104, I288, 10.1161/hc37t1.094596 Shapiro, 1991, Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon, J Clin Invest, 87, 1828, 10.1172/JCI115204 Tamarina, 1997, Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta, Surgery, 122, 264, 10.1016/S0039-6060(97)90017-9 Thompson, 1995, Production and localization of 92-kDa gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages, J Clin Invest, 96, 318, 10.1172/JCI118037 van der Rest, 1991, Collagen family of proteins, FASEB J, 5, 2814, 10.1096/fasebj.5.13.1916105 Visse, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry, Circ Res, 92, 827, 10.1161/01.RES.0000070112.80711.3D Wang, 2002, Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging, Hypertension, 39, 865, 10.1161/01.HYP.0000014506.13322.66 Werb, 1982, Elastases and elastin degradation, J Invest Dermatol, 79, 154s, 10.1111/1523-1747.ep12546056 Yanagisawa, 2002, Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo, Nature, 415, 168, 10.1038/415168a